Bengaluru-based Sophrosyne Technologies has strengthened India’s growing semiconductor momentum with a successful seed funding round of $2 million, led by Bluehill.VC. The investment marks a critical step as the company moves from prototype success toward commercial-grade silicon manufacturing, while expanding its engineering footprint and engaging with early customers across domestic and global markets. The capital infusion will support scaling of silicon design, firmware development, and deeper collaboration with wearable device makers seeking precision health-tracking capabilities with minimal power demands.
The company is designing a unified multi-vital biosensing SoC that can simultaneously measure ECG, PPG, respiration, and body temperature. With the wearable sector rapidly transitioning toward continuous health monitoring, Sophrosyne aims to deliver an SoC that dramatically improves battery efficiency and system integration — a combination that could redefine expectations for medical-grade accuracy in consumer devices.
Bluehill.VC’s managing partner Sridhar Parthasarathy emphasized the timeliness of this technology, stating that wearable health has reached an inflection point where accuracy and uninterrupted monitoring are essential. He highlighted that Sophrosyne’s architecture addresses the performance, efficiency and integration challenges that device makers struggle with and noted that Bluehill.VC is backing entrepreneurs who are building advanced semiconductor IP with global potential from India. He further expressed that the firm is proud to back deep tech founders building ambitious semiconductor IP from India.
The funding also serves as a meaningful validation for Sophrosyne’s leadership team. Co-founder and CEO Dr. Manish Srivastava remarked that this partnership is pivotal at the stage where the company is transitioning beyond R&D into production-grade silicon and OEM deployments. He added that having deep tech investors like Bluehill.VC, backed by leaders including Vinod Dham, Manu Iyer and Sridhar Parthasarathi, provides world class semiconductor guidance along with discipline and clarity to scale the technology globally.
With the semiconductor supply chain becoming a strategic focus for India, Sophrosyne’s progress underscores the country’s emerging ability to deliver advanced chip innovations tailored for high-growth sectors. As adoption of wearables accelerates and healthcare personalization becomes mainstream, the company is positioning itself to play a key role in shaping the future of connected health technology.
